Gentherm Reports Its 2014 Year-End And Fourth Quarter Results

NORTHVILLE, Mich., Feb. 24, 2015 /PRNewswire/ -- Gentherm (NASDAQ-GS:THRM), the global market leader and developer of innovative thermal management technologies, today announced its financial results for the fourth quarter and year ended December 31, 2014.

For the 2014 full year, revenues increased 23 percent year over year to $811.3 million and net income attributable to common shareholders more than doubled from the prior year to $70.1 million.

President and CEO Daniel R. Coker said, "We believe 2014 was a great year as we achieved nearly all of the goals we set out for ourselves, especially in growing our bottom line.  Our strong top line and bottom line results for 2014 again demonstrate our ability to drive revenues and profit as we expand globally in North America, Europe and Asia. We have doubled our business in the past three years and completed an important strategic acquisition, all of which has been accomplished with internal funding.

"In recent weeks, to better serve our customers all over the world, meet the demand for our products and balance our manufacturing needs as we grow, we opened a new office in Houston and began the process of building new manufacturing facilities in Vietnam and Macedonia," Coker added. "We are working hard to integrate the manufacturing skills of Global Thermoelectric, which is now the basis of our new Gentherm Power Technologies ("GPT") group, with Gentherm's technology and scientific advancements.  We are now poised to go after business not just in Global's legacy oil and gas markets but in the industrial and mobile power generation markets as well.

"One of our long term goals is to generate 25 percent of our revenue from non-automotive markets and we believe we are beginning to make progress in achieving that goal.  In addition to our bedding and mattress business, we are moving quickly forward with investigating new opportunities in the medical, aerospace, industrial and commercial consumer markets."

2014 Year-End Financial Highlights
For 2014, revenues were $811.3 million, compared with $662.1 million in 2013.  The year-over-year revenue increase was driven by continued strong shipments of the Company's CCS systems and $24.2 million in revenue from GPT.  CCS revenue increased year over year in 2014 by $84.8 million, or 32 percent, to $347.5 million.  Seat heater revenue increased year over year by $30.7 million, or 11 percent, to $313.2 million.  The Company also had significant growth in its heated steering wheel product with a year-over-year increase of $8.1 million, or 29 percent, to $36.1 million.

Foreign currency translation of the Company's Euro-denominated revenue for 2014, which was €154.6 million compared with €141.9 million during 2013, increased the US Dollar-reported product revenue by approximately $538,000.  The average US Dollar/Euro exchange rate for 2014 was 1.3317 compared with 1.3282 for 2013.

Net income attributable to common shareholders for 2014 was $70.1 million, or $1.98 per basic share and $1.95 per diluted share, which included $1.1 million in fees and expenses associated with the acquisition of GPT.  Net income attributable to common shareholders for 2013 was $32.2 million, or $0.96 per basic share and $0.94 per diluted share.  During 2013, the Company incurred $2.4 million in fees, legal and other expenses associated with the acquisition of shares in our German subsidiary.

Further non-cash purchase accounting impacts associated with the recent acquisitions are detailed in the Acquisition Transaction Expenses, Purchase Accounting Impacts and Other Effects table accompanying the release.

Gross margin as a percentage of revenue for 2014 was 29.8 percent compared with 26.4 percent for 2013. This increase was due to a favorable change in product mix, greater coverage of fixed manufacturing costs at the higher volume levels, favorable contribution from the Company's new electronics manufacturing facility in China and foreign currency impact on production expenses in the Mexican Peso and Ukraine Hryvna.  Additionally, the Company recorded a favorable adjustment to its warranty accrual totaling $3.7 million lowering its cost of sales during 2014.The favorable product mix is primarily due to the greater sales growth in CCS products on which Gentherm has historically had better margin performance.

Adjusted EBITDA for 2014 was $131.4 million compared with Adjusted EBITDA of $81.5 million for the comparable period of the prior year, an increase of $49.8 million or 61 percent.  Adjusted EBITDA (which is a non-GAAP measure) is provided to help shareholders understand Gentherm's results of operations due to the significant amount of acquisition-related amortization recorded against the Company's earnings.  This non-GAAP financial measure should be viewed in addition to, and not as an alternative for, Gentherm's reported results prepared in accordance with GAAP.

The Company's balance sheet as of December 31, 2014, had total cash and cash equivalents of $85.7 million, total assets of $557.9 million, shareholders' equity of $294.2 million and total debt of $90.8 million.

Fourth Quarter Financial Highlights
For the 2014 fourth quarter, revenues were up 13 percent to $205.2 million from $182.3 million in the prior year period.  The year-over-year revenue increase was driven by continued strong shipments of the Company's CCS systems and $7.5 million in revenue from GPT. 

"Revenue for the fourth quarter came in as we expected," Coker said. "We were, however, unfavorably impacted by fluctuations in foreign currency exchange rates including the dramatic drop in the value of the Euro which lowered our fourth quarter revenues by $4.6 million compared to 2013. Despite this, we again hit our goals and targets."

Foreign currency translation of the Company's Euro-denominated product revenue for this year's fourth quarter had an impact on its product revenue results since the average U.S. Dollar/Euro exchange rate in this year's fourth quarter was 1.2488 compared to 1.3694 in the fourth quarter of 2013.  Gentherm product revenues denominated in the Euro were €38.3 million during the fourth quarter of 2014 versus €35.8 million during the fourth quarter of 2013.  Further weakening in the Euro since the end of the 2014 fourth quarter will continue to have an unfavorable impact on our revenues during future periods.

CCS revenue in the 2014 fourth quarter, compared to the 2013 fourth quarter, increased by $16.6 million, or 22 percent, to $92.6 million.  This increase was partially the result of new program launches since the fourth quarter 2013 and strong production volumes and sales of vehicles equipped with CCS systems, particularly vehicles in the luxury segment.  Additionally, certain vehicles that have been redesigned since the 2013 fourth quarter are experiencing very strong production and sales levels, including the General Motors full size SUV platform ("K2XX") and the Jeep Grand Cherokee. 

Seat heater revenue in this year's fourth quarter decreased year over year by approximately $3.1 million, or 4 percent, to $72.5 million, reflecting the unfavorable Euro exchange rate and the impact of higher CCS volumes which sometimes contain seat heater elements.  These were partially offset by strong production volumes on General Motors' K2XX platform.  The Company also had significant sales growth of its steering wheel heater product, which increased $1.3 million, or 16 percent year over year, to $9.4 million

Net income attributable to common shareholders for the 2014 fourth quarter was $19.8 million, or $0.56 per basic share and $0.55 per diluted share.  Net income attributable to common shareholders for the fourth quarter of 2013 was $11.0 million, or $0.31 per basic and diluted share, which included $503,000 in fees, legal and other expenses associated with the acquisition of additional shares in our German subsidiary.  The Company did not incur any such expenses in the fourth quarter of 2014. 

Gross margin as a percentage of revenue for this year's fourth quarter increased to 30.3 percent, up from 27.2 percent for the 2013 fourth quarter. 

Adjusted EBITDA for the 2014 fourth quarter was $35.7 million, up $10.0 million or 39 percent, compared with Adjusted EBITDA of $25.6 million for the 2013 fourth quarter. 

Research and Development, Selling, General and Administrative (SG&A) Expenses
Net research and development expenses for 2014 fourth quarter and full year were up year over year $1.7 million, or 13 percent, and $7.7 million, or 15 percent, respectively, to a respective $14.7 million and $57.5 million, when compared to the prior year periods.  The increases reflect additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products.  The increases in net research and development expenses in the 2014 fourth quarter and full year also include $276,000 and $850,000, respectively, due to the inclusion of GPT.  New product development includes automotive heated and cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices and other potential products. 

Selling, general and administrative expenses for the 2014 fourth quarter and full year were $22.9 million and $84.6 million, respectively.  These amounts included selling, general and administrative expenses of GPT, which was acquired during 2014, totaling $2.2 million and $6.2 million in the 2014 fourth quarter and full year, respectively.  The remaining increase in selling, general and administrative expenses totaled $1.5 million and $6.3 million, or 8 percent and 10 percent, respectively, for the 2014 fourth quarter and full year.  These increases in expenses are due to increased management incentive compensation costs, higher general legal, audit and travel costs, as well as wages and benefits costs resulting from new employee hiring and merit increases.  The additional employees are primarily related to establishing a new electronics production facility in Shenzhen, China, and increasing sales and marketing efforts aimed at supporting our current product development strategy.

Guidance
Barring unforeseen economic turbulence, including in the European market or further unfavorable fluctuations of the Euro exchange rate, the 2015 revenue growth outlook remains strong.  The Company is expecting revenue for 2015 to increase 10 to 15 percent over 2014 revenue, which was $811 million

Conference Call
As previously announced, Gentherm is conducting a conference call today to be broadcast live over the Internet at 11:30 AM Eastern Time to review these financial results.  The dial-in number for the call is 1-877-407-4018 or 1-201-689-8471.  The live webcast and archived replay of the call can be accessed in the Events page of the Investor section of Gentherm's website at www.gentherm.com.

About Gentherm
Gentherm (NASDAQ-GS:THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include actively heated and cooled seat systems and cup holders, heated and ventilated seat systems, thermal storage bins, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), cable systems and other electronic devices.  The Company's advanced technology team is developing more efficient materials for thermoelectric and systems for waste heat recovery and electrical power generation for the automotive markets that may have far-reaching applications for consumer products as well as industrial and technology markets.  Gentherm more than 9,000 employees in facilities in the U.S., Germany, Mexico, China, Canada, Japan, England, Korea, Malta, Hungary and the Ukraine.  For more information, go to www.gentherm.com.

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include statements regarding future sales, products, opportunities, markets, expenses and profits. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. Those risks include, but are not limited to, risks that sales may not increase, additional financing requirements may not be available, new competitors may arise and adverse conditions in the industry in which the Company operates may negatively affect its results. Those and other risks are described in the Company's annual report on Form 10-K for the year ended December 31, 2013 and subsequent reports filed with the Securities and Exchange Commission (SEC), copies of which are available from the SEC or may be obtained from the Company. Except as required by law, the Company assumes no obligation to update the forward-looking statements, which are made as of the date hereof, even if new information becomes available in the future.

Contact:

Allen & Caron Inc


Mike Mason (investors)


michaelm@allencaron.com    


(212) 691-8087


Rene Caron (investors)


rene@allencaron.com 


Len Hall (media)


len@allencaron.com


(949) 474-4300

 

TABLES FOLLOW

GENTHERM INCORPORATED


CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)



Three Months Ended
December 31,

Twelve Months Ended
December 31,


2014

2013

2014

2013

Product revenues

$

205,168

$

182,290

$

811,300

$

662,082

Cost of sales


142,853


132,648


569,618


487,320

Gross margin


62,315


49,642


241,682


174,762

Operating expenses:









Net research and development expenses


14,653


12,911


57,526


49,873

Acquisition transaction expenses



503


1,075


2,414

Selling, general and administrative


22,906


19,211


84,647


72,091

Total operating expenses


37,559


32,625


143,248


124,378

Operating income


24,756


17,017


98,434


50,384

Interest expense


(504)


(627)


(3,262)


(3,543)

Debt retirement expense


(640)



(1,370)


Revaluation of derivatives


(225)


(195)


(518)


1,006

Foreign currency (loss) gain


687


(714)


(218)


(2,228)

Income from equity investment



117


785


436

Other income


201


87


370


175

Earnings before income tax


24,275


15,685


94,221


46,230

Income tax expense


4,446


4,754


24,102


11,097

Net income


19,829


10,931


70,119


35,133

(Income) loss attributable to non-controlling interest



27



(1,313)

Net income attributable to Gentherm Incorporated


19,829


10,958


70,119


33,820

Convertible preferred stock dividends





(1,622)

Net income attributable to common shareholders

$

19,829

$

10,958

$

70,119

$

32,198

Basic earnings per share

$

0.56

$

0.31

$

1.98

$

0.96

Diluted earnings per share

$

0.55

$

0.31

$

1.95

$

0.94

Weighted average number of shares – basic


35,691


34,814


35,412


33,653

Weighted average number of shares – diluted


36,232


35,274


36,049


34,124

 

GENTHERM INCORPORATED

RECONCILIATION OF ADJUSTED EBITDA TO NET INCOME

(Unaudited, in thousands)



     Three Months Ended

  December 31,

    Twelve Months Ended

  December 31,


2014

2013

2014

2013

Net income

$       19,829

$       10,931

$       70,119

$       35,133

Add Back:





   Income tax expense

4,446

4,754

24,102

11,097

   Interest expense

504

627

3,262

3,543

   Depreciation and amortization

10,514

7,611

34,652

30,441

Adjustments:





   Debt retirement expense

640

1,370

   Acquisition transaction expense

503

1,075

2,414

   Unrealized currency (gain) loss

(491)

1,002

(1,168)

2,131

   Unrealized revaluation of derivatives

225

195

(2,049)

(3,219)

Adjusted EBITDA

$       35,667

$       25,623

$     131,363

$       81,540

 

Use of Non-GAAP Financial Measures
In evaluating its business, Gentherm considers and uses Adjusted EBITDA as a supplemental measure of its operating performance.  The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, transaction expenses, debt retirement expenses, unrealized currency gain or loss and unrealized revaluation of derivatives.  Management believes that Adjusted EBITDA is a meaningful measure of liquidity and the Company's ability to service debt because it provides a measure of cash available for such purposes. Management provides an Adjusted EBITDA measure so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis.

The term Adjusted EBITDA is not defined under GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with GAAP.  Adjusted EBITDA has limitations as an analytical tool, and when assessing the Company's operating performance, investors should not consider Adjusted EBITDA in isolation, or as a substitute for net income or other consolidated income statement data prepared in accordance with GAAP.  Gentherm compensates for these limitations by relying primarily on its GAAP results and using Adjusted EBITDA only supplementally.

GENTHERM INCORPORATED

ACQUISITION TRANSACTION EXPENSES, PURCHASE ACCOUNTING IMPACTS AND OTHER EFFECTS

(Unaudited and in thousands, except per share data)










  Three Months Ended

  December 31,

Twelve Months Ended
December 31,

Future  Full Year Periods (estimated)


2014

2013

2014

2013

2015

2016

2017

Thereafter










Transaction related current expenses









Acquisition transaction expenses

$  –

$  503

$  1,075

$  2,414

$  –

$  –

$  –

$  –

Non-cash purchase accounting impacts









Customer relationships amortization

$  1,985

$  2,054

$  8,205

$  7,969

$  7,719

$  7,719

$  7,719

$  26,607

Technology amortization

854

861

3,486

3,342

3,321

3,321

2,380

2,253

Product development costs amortization

519

569

2,207

2,206

1,142

46

Trade name amortization

50

104

197

197

148

Order backlog amortization

832

Inventory fair value adjustment

1,098


$  3,408

$  3,484

$ 15,932

$ 13,517

$  12,379

$  11,283

$  10,247

$  28,860

Tax effect

(794)

(1,002)

(4,121)

(4,068)

(2,884)

(2,630)

(2,389)

(6,781)

Net income effect

2,614

2,985

12,886

11,863

9,495

8,653

7,858

22,079

Non-controlling interest effect

(155)

Net income available to shareholders effect

$  2,614

$  2,985

$ 12,886

$ 11,708

$  9,495

$  8,653

$  7,858

$  22,079










Earnings per share - difference









Basic

$  0.07

$  0.09

$  0.36

$  0.35





Diluted

$  0.07

$  0.08

$  0.36

$  0.34





 

GENTHERM INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)




December 31,




2014



2013


ASSETS









Current Assets:









Cash & cash equivalents


$

85,700



$

54,885


Accounts receivable, less allowance of $2,847 and $1,807, respectively



136,183




118,283


Inventory



77,643




64,217


Derivative financial instruments



145




67


Deferred income tax assets



6,247




10,616


Prepaid expenses and other assets



29,107




21,864


Total current assets



335,025




269,932


Property and equipment, net



91,727




79,234


Goodwill



30,398




25,809


Other intangible assets, net of accumulated amortization of $95,946 and $44,474, respectively



68,129




83,431


Deferred financing costs



406




1,072


Deferred income tax assets



18,843




7,103


Derivative financial instruments



1,345




1,969


Other non-current assets



12,019




13,373


Total assets


$

557,892



$

481,923


LIABILITIES AND SHAREHOLDERS' EQUITY









Current Liabilities:









Accounts payable


$

71,434



$

61,662


Accrued liabilities



68,387




66,783


Current maturities of long-term debt



5,306




21,439


Derivative financial instruments



2,466




2,552


Deferred income tax liabilities






710


Total current liabilities



147,593




153,146


Pension benefit obligation



10,321




6,868


Other Liabilities



2,788




1,601


Long-term debt, less current maturities



85,469




60,881


Derivative financial instruments



6,698




9,358


Deferred tax liabilities



10,804




17,975


Total liabilities



263,673




249,829


Shareholders' equity:









Common Stock:









No par value; 55,000,000 shares authorized, 35,696,742 and 34,929,334 issued and outstanding at December 31, 2014 and 2013, respectively



243,255




232,067


Paid-in capital



(8,224)




(9,582)


Accumulated other comprehensive income



(25,743)




(5,203)


Accumulated earnings



84,931




14,812


Total shareholders' equity



294,219




232,094


Total liabilities and shareholders' equity


$

557,892



$

481,923


 

GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)




Year Ended December 31,




2014



2013



2012


Operating Activities:













Net income


$

70,119



$

35,133



$

24,321


Adjustments to reconcile net income to cash provided by operating activities:













Depreciation and amortization



35,029




31,249




30,627


Deferred income tax expense (benefit)



(11,103)




(2,121)




618


(Gain) loss on revaluation of derivatives



(1,039)




(2,678)




167


Debt extinguishment expenses



1,370








Stock compensation



4,652




2,636




1,252


Loss on sale of property, plant & equipment



131




106




555


Provision for doubtful accounts



1,017




(705)




533


Defined benefit pension plan expense



820




(659)




50


(Gain) loss from equity investment



(785)




(436)




82


Changes in operating assets and liabilities:













Accounts receivable



(16,902)




(13,828)




(18,367)


Inventory



(8,367)




(9,600)




(5,847)


Prepaid expenses and other assets



(5,871)




(9,446)




(3,228)


Accounts payable



6,956




18,255




1,788


Accrued liabilities



4,308




11,888




4,314


Net cash provided by operating activities



80,335




59,794




36,865


Investing Activities:













Purchases of derivative financial instruments









(7,787)


Purchase of non-controlling interest






(48,567)





Investment in subsidiary, net of cash acquired



(31,474)








Loan to equity investment









(590)


Cash invested in corporate owned life insurance






(266)




(265)


Purchases of property and equipment



(38,887)




(35,861)




(26,793)


Proceeds from the sale of property and equipment



487




11




40


Net cash used in investing activities



(69,874)




(84,683)




(35,395)


Financing Activities:













Distribution paid to non-controlling interest






(3)




(290)


Cash paid for financing costs



(1,139)







(264)


Borrowing of Debt



91,592




45,669




3,326


Repayments of Debt



(79,692)




(24,496)




(22,953)


Proceeds from public offering of common stock









75,532


Cancellation of restricted stock



(1,113)








Excess tax benefit from equity awards



1,831




2,074




171


Proceeds from sale of W.E.T. equity to non-controlling interest









1,921


Redemption of Series C Preferred Stock






(8,446)




(23,340)


Series C Preferred Stock Holders dividend






(696)




(2,400)


Proceeds from the exercise of Common Stock options



7,176




4,801




774


Net cash provided by financing activities



18,655




18,903




32,477


Foreign currency effect on cash and cash equivalents



1,699




2,719




366


Net (decrease) increase in cash and cash equivalents



30,815




(3,267)




34,313


Cash and cash equivalents at beginning of period



54,885




58,152




23,839


Cash and cash equivalents at end of period


$

85,700



$

54,885



$

58,152


Supplemental disclosure of cash flow information:













Cash paid for interest


$

2,558



$

2,653



$

3,545


Cash paid for taxes


$

21,756



$

11,326



$

8,445


Supplemental disclosure of non-cash transactions:













Issuance of Common Stock to non-controlling interest


$



$

42,517



$

7,780


Issuance of Common Stock for Series C Preferred Stock conversion


$



$

15,108



$

1,031


Capital Lease






3,254





Common stock issued to directors and employees


$

2,706



$

1,509



$

429


 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gentherm-reports-its-2014-year-end-and-fourth-quarter-results-300040188.html

SOURCE Gentherm

Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.